AMGEN (AMGN) Income Statement
Is this a real, growing, cash-generative business, or a story propped up by accounting?
573.0mn → 542.0mn diluted shares since FY21. Part of EPS growth is the shrinking denominator. Watch net income too.
▲70% YoY in FY25, largest jump in this window; watch free-cash-flow conversion.
$5.1B returned vs $8.1B of FCF in FY25. Buybacks + dividends covered by cash flow.
21¢ of every revenue dollar becomes profit. The biggest cost lever is operating expenses.
Over this window: gross 75.2% → 67.2%. Net margin 21.0% is more than double the sector median.
| Line item | TTM † | FY25 | FY24 | FY23 | FY22 | FY21 | YoY | CAGR 21→25 |
|---|---|---|---|---|---|---|---|---|
| Revenue & profitability | ||||||||
Revenue | 38,903.0 | 36,751.0 | 33,424.0 | 28,190.0 | 26,323.0 | 25,979.0 | ▲10.0% | +9.1% |
Cost of revenue | 11,319.0 | 12,037.0 | 12,858.0 | 8,451.0 | 6,406.0 | 6,454.0 | ▼6.4% | +16.9% |
Gross profit | 27,584.0 | 24,714.0 | 20,566.0 | 19,739.0 | 19,917.0 | 19,525.0 | ▲20.2% | +6.1% |
Research & development | 7,840.0 | 7,272.0 | 5,964.0 | 4,784.0 | 4,434.0 | 6,324.0 | ▲21.9% | +3.6% |
Selling, general & admin | 8,291.0 | 8,362.0 | 7,344.0 | 7,058.0 | 5,917.0 | 5,562.0 | ▲13.9% | +10.7% |
Total operating expenses | 14,974.0 | 15,634.0 | 13,308.0 | 11,842.0 | 10,351.0 | 11,886.0 | ▲17.5% | +7.1% |
Operating incomefeeds ROC rank | 12,610.0 | 9,080.0 | 7,258.0 | 7,897.0 | 9,566.0 | 7,639.0 | ▲25.1% | +4.4% |
Other income, net | −1,558.0 | −104.0 | −2,649.0 | −42.0 | −2,220.0 | −938.0 | — | — |
Pretax income | 11,052.0 | 8,976.0 | 4,609.0 | 7,855.0 | 7,346.0 | 6,701.0 | ▲94.7% | +7.6% |
Income tax | 1,661.0 | 1,265.0 | 519.0 | 1,138.0 | 794.0 | 808.0 | ▲143.7% | +11.9% |
Net incomePiotroski ROA ✓feeds Buffett Quality owner earnings | 9,391.0 | 7,711.0 | 4,090.0 | 6,717.0 | 6,552.0 | 5,893.0 | ▲88.5% | +7.0% |
| Per share | ||||||||
Diluted EPSbuyback-sensitive | 17.24 | 14.23 | 7.56 | 12.49 | 12.11 | 10.28 | ▲88.2% | +8.5% |
Diluted shares (mn) | 546.00 | 542.00 | 541.00 | 538.00 | 541.00 | 573.00 | ▲0.2% | −1.4% |
| Margins | ||||||||
Gross margin59th pct in Healthcare | 70.9% | 67.2% | 61.5% | 70.0% | 75.7% | 75.2% | ▲5.7pp | −7.9pp |
Operating margin | 32.4% | 24.7% | 21.7% | 28.0% | 36.3% | 29.4% | ▲3.0pp | −4.7pp |
Net margin89th pct in Healthcare | 24.1% | 21.0% | 12.2% | 23.8% | 24.9% | 22.7% | ▲8.7pp | −1.7pp |
Statements normalized in our fundamentals DB · Not investment advice.
Common questions
What was AMGEN's revenue last fiscal year?
AMGEN reported revenue of $36.8B in fiscal 2025, up 10.0% from fiscal 2024.
What was AMGEN's net income?
AMGEN reported net income of $7.7B in fiscal 2025, a net margin of 21.0%.

